Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 14

    1.

    TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis.

    Fujisawa K, Nishikawa T, Kukidome D, Imoto K, Yamashiro T, Motoshima H, Matsumura T, Araki E.

    Biochem Biophys Res Commun. 2009 Jan 30;379(1):43-8. Epub 2008 Dec 11.PMID: 19084501 [PubMed - indexed for MEDLINE]Related articles

    2.

    Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice.

    Goto H, Nishikawa T, Sonoda K, Kondo T, Kukidome D, Fujisawa K, Yamashiro T, Motoshima H, Matsumura T, Tsuruzoe K, Araki E.

    Biochem Biophys Res Commun. 2008 Feb 15;366(3):814-20. Epub 2007 Dec 18.PMID: 18083119 [PubMed - indexed for MEDLINE]Related articles

    3.

    Impact of mitochondrial ROS production in the pathogenesis of insulin resistance.

    Nishikawa T, Kukidome D, Sonoda K, Fujisawa K, Matsuhisa T, Motoshima H, Matsumura T, Araki E.

    Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S161-4. Epub 2007 May 3.PMID: 17481767 [PubMed - indexed for MEDLINE]Related articles

    4.

    Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.

    Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, Taketa K, Motoshima H, Taguchi T, Sonoda K, Kukidome D, Takuwa Y, Kawada T, Brownlee M, Nishikawa T, Araki E.

    Circ Res. 2007 May 25;100(10):1442-51. Epub 2007 Apr 26.PMID: 17463321 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Impact of mitochondrial ROS production on diabetic vascular complications.

    Nishikawa T, Kukidome D, Sonoda K, Fujisawa K, Matsuhisa T, Motoshima H, Matsumura T, Araki E.

    Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S41-5. Epub 2007 Apr 23.PMID: 17452060 [PubMed - indexed for MEDLINE]Related articles

    6.

    Troglitazone inhibits oxidized low-density lipoprotein-induced macrophage proliferation: impact of the suppression of nuclear translocation of ERK1/2.

    Yano M, Matsumura T, Senokuchi T, Ishii N, Motoshima H, Taguchi T, Matsuo T, Sonoda K, Kukidome D, Sakai M, Kawada T, Nishikawa T, Araki E.

    Atherosclerosis. 2007 Mar;191(1):22-32. Epub 2006 May 24.PMID: 16725145 [PubMed - indexed for MEDLINE]Related articles

    7.

    Impact of mitochondrial reactive oxygen species and apoptosis signal-regulating kinase 1 on insulin signaling.

    Imoto K, Kukidome D, Nishikawa T, Matsuhisa T, Sonoda K, Fujisawa K, Yano M, Motoshima H, Taguchi T, Tsuruzoe K, Matsumura T, Ichijo H, Araki E.

    Diabetes. 2006 May;55(5):1197-204.PMID: 16644673 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells.

    Kukidome D, Nishikawa T, Sonoda K, Imoto K, Fujisawa K, Yano M, Motoshima H, Taguchi T, Matsumura T, Araki E.

    Diabetes. 2006 Jan;55(1):120-7.PMID: 16380484 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.

    Igata M, Motoshima H, Tsuruzoe K, Kojima K, Matsumura T, Kondo T, Taguchi T, Nakamaru K, Yano M, Kukidome D, Matsumoto K, Toyonaga T, Asano T, Nishikawa T, Araki E.

    Circ Res. 2005 Oct 14;97(8):837-44. Epub 2005 Sep 8.PMID: 16151020 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Statins suppress oxidized low density lipoprotein-induced macrophage proliferation by inactivation of the small G protein-p38 MAPK pathway.

    Senokuchi T, Matsumura T, Sakai M, Yano M, Taguchi T, Matsuo T, Sonoda K, Kukidome D, Imoto K, Nishikawa T, Kim-Mitsuyama S, Takuwa Y, Araki E.

    J Biol Chem. 2005 Feb 25;280(8):6627-33. Epub 2004 Dec 17.PMID: 15611087 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase mediate macrophage proliferation induced by oxidized low-density lipoprotein.

    Senokuchi T, Matsumura T, Sakai M, Matsuo T, Yano M, Kiritoshi S, Sonoda K, Kukidome D, Nishikawa T, Araki E.

    Atherosclerosis. 2004 Oct;176(2):233-45.PMID: 15380445 [PubMed - indexed for MEDLINE]Related articles

    12.

    15d-PGJ2 inhibits oxidized LDL-induced macrophage proliferation by inhibition of GM-CSF production via inactivation of NF-kappaB.

    Matsuo T, Matsumura T, Sakai M, Senokuchi T, Yano M, Kiritoshi S, Sonoda K, Kukidome D, Pestell RG, Brownlee M, Nishikawa T, Araki E.

    Biochem Biophys Res Commun. 2004 Feb 13;314(3):817-23.PMID: 14741709 [PubMed - indexed for MEDLINE]Related articles

    13.

    Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy.

    Kiritoshi S, Nishikawa T, Sonoda K, Kukidome D, Senokuchi T, Matsuo T, Matsumura T, Tokunaga H, Brownlee M, Araki E.

    Diabetes. 2003 Oct;52(10):2570-7.PMID: 14514642 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes.

    Nishikawa T, Sasahara T, Kiritoshi S, Sonoda K, Senokuchi T, Matsuo T, Kukidome D, Wake N, Matsumura T, Miyamura N, Sakakida M, Kishikawa H, Araki E.

    Diabetes Care. 2003 May;26(5):1507-12.PMID: 12716813 [PubMed - indexed for MEDLINE]Related articlesFree article